Dr. Rekha Chaudhary, a medical hematologist-oncologist and assistant professor of medicine at the University of Cincinnati, explains that
tumor infiltrating lymphocyte (TIL) therapy is an
intensive process and may not be recommended for every patient. Your doctor will determine if you are healthy enough to undergo this treatment. Talk to your doctor about whether TIL therapy could be an option for you.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about melanoma which will help other patients, caregivers and families.